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BRIEF DEFINITIVE REPORT
            Signals emanating from the ER induce a tran-
scriptional program that enables cells to survive 
ER stress. This highly coordinated response is 
essential for the folding, processing, export, and 
degradation of all proteins emanating from the 
ER during stressed and normal conditions. Ex-
amples of physiological conditions that require 
the unfolded protein response (UPR) include 
plasma cell diff  erentiation (  1  ) and pancreatic 
      cell function (  2  ). Adaptation of tumor cells 
to hypoxic conditions and glucose deprivation 
also induces the ER stress response (  3  ). Addi-
tionally, there is increasing evidence of protein 
misfolding in neurodegenerative diseases such as 
Huntington  ’  s, Alzheimer  ’  s, and prion-related 
diseases (  4  ).The UPR exists in all eukaryotes 
and consists of multiple signaling pathways, the 
most conserved of which is mediated by IRE1. 
Upon sensing unfolded proteins, IRE1 oligo-
merizes, is activated by autophosphorylation, 
and uses its endoribonuclease activity to excise 
an intron from the transcription factor Hac1p 
in yeast or its mammalian homologue, XBP-1, 
a cyclic-AMP response element binding protein/
activating transcription factor family member 
fi  rst isolated in our laboratory (  5  ). This uncon-
ventional mRNA splicing event results in the 
conversion of the inactive 267  –  amino-acid un-
spliced XBP-1 (XBP-1u) protein to an active 
371  –  amino-acid spliced XBP-1 (XBP-1s) pro-
tein (  6  –  8  ). We have previously shown that XBP-1 
is essential for the diff  erentiation of highly se-
cretory cells, including embryonic hepatocytes, 
exocrine pancreatic acinar cells, and plasma 
cells (  1, 9  –  11  ). 
  Much has been learned about the factors 
that control DC diff  erentiation. The fms-related 
tyrosine kinase 3 ligand (Flt3L) (  12, 13  ) and 
GM-CSF (  14, 15  ) are well known positive 
regulators of DC development. A more recent 
study described the involvement of Toll-like 
receptor (TLR) stimulation in hematopoietic 
cell proliferation and subsequent DC diff  eren-
tiation (  16  ). Additionally, several intracellular 
signaling molecules and transcription factors  —
  including Gfi  1, Id2, Ikaros, IFN regulatory 
factor 2 (IRF-2), IRF-4, IRF-8, relB, Runx3, 
Spi-B, and STAT3  —  that aff  ect the develop-
ment of individual DC subsets in vivo have been 
reported (  17  –  24  ). The control of DC survival 
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oligonucleotides (ODNs; unpublished data). However, to 
our surprise, analysis of the relative amounts of XBP-1s ver-
sus XBP-1u transcripts by RT-PCR revealed that freshly iso-
lated DC subsets spontaneously exhibited high levels of XBP-1 
splicing relative to unactivated T and B lymphocytes (  Fig. 
2 B  ). We also examined the transformed mouse DC line 
CY15 (  31  ) and found that it also exhibited high levels of 
XBP-1 splicing. Protein levels of the spliced version of XBP 
in DCs and the CY15 DC line were determined by Western 
blot analysis and were elevated, consistent with the mRNA 
expression and splicing experiments (  Fig. 2 C  ). These results 
stand in marked contrast to the low levels of XBP-1 mRNA 
and absent XBP-1 splicing observed in mature B cells before 
their diff  erentiation to plasma cells (  11  ). However, like the 
XBP-1  –  defi  cient terminally diff  erentiated B cells and pan-
creatic acinar cells (  10, 32  ), pDCs without XBP-1 lacked the 
highly elaborate rough ER with multiple layers of closely spaced 
cisternae seen in WT pDCs; instead, the ER in the mutant 
pDCs was poorly developed and had few, disorganized cis-
ternae (  Fig. 2 D  ). Further, such XBP-1  –  defi  cient pDCs had 
markedly reduced production of the major pDC cytokine, 
IFN-      (  Fig. 2 E  ). 
  The chimeric mice used in this study were produced 
by the injection of XBP-1       /       embryonic stem cells into 
C57BL/6  –  RAG-2       /       blastocysts. Hence, it was likely that 
the defect found in DCs and pDCs was cell autonomous 
for XBP-1       /       hematopoietic precursor cells. Therefore, we 
considered that high basal level expression of XBP-1s might 
infl  uence DC development or survival. We tested this hy-
pothesis by using a Flt3L-based in vitro culture system to 
generate DCs. Lin        IL-7R             Thy1.1        c-Kit     Ly9      BM cells 
were sorted from 129/RAG2       /       and XBP-1/RAG-2       /       
chimeric mice. BM cultures were analyzed for cell number 
and CD11c      cell production at days 6 and 9. As expected, 
phenotypic analysis showed that WT BM cultures were able 
to produce CD11c      and CD11c     B220      cells. Consistent 
with the in vivo data described above, XBP-1       /       BM cul-
tures produced fewer CD11c      or CD11c     B220      cells (  Fig. 
3, A and B  ).   Indeed, XBP-1       /       BM cultures were mainly 
composed of cells that stained exclusively for CD11c      but 
not cells expressing both CD11c      and B220 by day 6. By 
day 9 of culture, XBP-1       /       BM cultures did yield CD11c      
and B220      cells; however, the numbers were greatly reduced 
(  Fig. 3, A and B  ). 
  A previous study demonstrated that in vitro and in vivo 
pDC and DC diff  erentiation potential is restricted to Flt3-
expressing hematopoietic progenitors (  33  ). To determine if 
XBP-1 may infl  uence the ability of pDCs and DCs to de-
velop from these committed progenitors, we used a bicistronic 
retroviral transduction system to transduce the spliced form 
of mouse XBP-1 into progenitor cells. This approach also 
enabled us to test whether ectopically expressed XBP-1s in 
XBP-1       /       progenitors can rescue the developmental defect. 
Lin        IL-7R        Thy1.1        c-Kit     Ly9      BM cells were sorted into 
Flt3         and Flt3      cell fractions. Of note, there was no dif-
ference in the percentage of Flt3      progenitors between 
plays an important role in regulating T cell activation and 
function. Components of the immune system involved in DC 
survival include TLR stimulation and engagement of CD40 
on the DC by CD154 expressed on activated T cells. Stud-
ies with infl  ammatory cytokines and tumor necrosis  –  related 
activation-induced cytokine/receptor activator for NF-     B 
demonstrated an augmentation of T cell priming through an 
enhanced DC survival response (  25, 26  ). The intracellular 
signaling pathway mediated by the NF-     B family has been 
shown to be responsible for the enhancement of DC sur-
vival by these stimuli (  27, 28  ). Because the ER stress response 
functions to regulate the balance between homeostasis and 
apoptosis, we asked whether the UPR and, in particular, the 
IRE1/XBP-1 branch of the UPR might contribute to the 
diff  erentiation and survival of the DC (  29  ). 
    RESULTS AND DISCUSSION   
  Flow cytometric analysis of DC-enriched low density frac-
tions from spleens of XBP-1/RAG-2       /       chimeric mice and 
control 129/RAG-2       /       chimeric or 129/SvImJ mice was 
performed using the surface markers CD11c and CD11b. The 
total number of spleen cells was the same in XBP-1/RAG-2       /       
and control mice. However, the percentage of CD11c      
CD11b      DCs was markedly reduced in XBP-1/RAG-2       /       
mice compared with control animals (  Fig. 1 A  ).   The CD11c      
population was further subdivided by the expression of 
CD4 and CD8 into two subsets (CD11c  hi  CD4        CD8      and 
CD11c  hi  CD4     CD8). Both subsets were decreased in XBP-1/
RAG-2       /       versus control chimeric mice (  Fig. 1, B and C  ). 
Interestingly, the most profound reduction was observed 
in a third subset of DCs, the plasmacytoid DCs (pDCs). 
This DC subset is characterized by the surface phenotype 
CD11c  int  B220     DX5         and displays extensive ER expansion 
and high level secretion of the cytokine IFN-      (  Fig. 1 A  ) (  30  ). 
As we previously reported, XBP-1/RAG-2       /       versus con-
trol chimeric mice had similar numbers of CD19     , CD3     , 
and CD11b      CD11c         cells when compared with WT (  Fig. 
1 C, bottom  ) (  1  ). In the absence of stimulation, CD11c      DCs 
express low levels of co-stimulatory molecules such as CD86 
and moderate levels of MHC class II. However, splenic DCs 
from XBP-1/RAG-2       /       mice constitutively expressed higher 
levels of these activation markers (  Fig. 1 D  ). This hyperacti-
vated state was most profound in the pDC (CD11c  int  B220     ) 
population. Thus, XBP-1 RAG-2       /       mice had reduced 
numbers of both conventional and pDCs, and these DCs 
were hyperactivated. 
  To understand how XBP-1 controls DC number, we 
examined XBP-1 mRNA expression and splicing by real-
time PCR to assess whether total levels of XBP-1 mRNA 
and/or the extent of XBP-1 splicing correlated with DC dif-
ferentiation. As shown in   Fig. 2 A  , total XBP-1 mRNA tran-
scripts including both the unspliced and spliced versions of 
XBP-1 were expressed at high levels in the pDC subset 
relative to immature conventional DCs and unactivated T 
and B lymphocytes.   This expression was not further increased 
upon stimulation with TLR ligands such as LPS and CpG JEM VOL. 204, October 1, 2007  2269
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XBP-1s  –    GFP    –  transduced Flt3         progenitors gave rise to no 
pDCs or DCs (unpublished data). As seen in untransduced pro-
genitors,  GFP  -transduced WT progenitors produced signifi  -
cantly greater numbers of both pDCs and DCs when compared 
with   GFP  -transduced XBP-1       /       BM progenitors (  Fig. 3, 
C and D  ). Interestingly, XBP-1s  –    GFP    –  transduced Flt3      WT 
progenitors produced a signifi  cantly higher percentage of and 
total numbers of both pDCs and DCs compared with   GFP  -
transduced Flt3      progenitors (  Fig. 3, C and D  ). Surprisingly, 
WT and XBP-1       /       BM cells (unpublished data). There-
fore, the absence of XBP-1 did not aff  ect diff  erentiation to 
the Flt3      progenitor stage. To study the eff  ects of enforced 
XBP-1 expression on pDC and DC development, Flt3         and 
Flt3      progenitors were transduced with control-  GFP   or 
XBp-1s    –    GFP     retroviruses and cultured in mouse Flt3L  –   and 
stem cell factor (SCF)  –  supplemented media. Cultures were 
analyzed for cell number and the presence of pDCs and 
DCs at day 6. As expected, control   GFP  -transduced or 
  Figure 1.     XBP-1  –  defi  cient lymphoid chimeras have reduced numbers of conventional and pDCs. (A) Low density mouse spleen cells from WT or 
XBP-1      /      animals were isolated and depleted of CD19      and DX5      cells by immunomagnetic bead negative selection. DCs were analyzed by fl  ow cytometry 
for CD11b or B220 staining on CD11c      cells (CD19       DX5       ). (B) CD4 and CD8      staining of CD11c      (CD19      DX5       )-enriched low density mouse spleen cells from 
WT or XBP-1      /      animals. (C) Percentage of splenic DC (top) and lymphocyte (bottom subsets from WT (shaded bar) or XBP-1      /      (open bar) animals. The data 
represent the mean + SEM (  n     3). Values in A represent the percentage of each DC subset from low density mouse spleen cells isolated and depleted of 
CD19      and DX5      cells by immunomagnetic bead negative selection. Values for lymphocyte subsets in B represent percentages from unenriched low density 
spleen preparations. *, P       0.02 when comparing WT with XBP-1 samples; **, NS. (D) Activated phenotype of XBP-1      /      splenic DCs. Enriched low density 
populations from WT and XBP-1      /      animals were gated for CD11c      and CD11c    B220     subsets and analyzed for CD86 and MHC class II expression. Numbers 
indicate the percentage of cells in each CD11c      subset. The experiment shown is representative of three independent experiments performed.     2270 A REQUIREMENT FOR XBP-1 IN NORMAL AND MALIGNANT DENDRITIC CELLS | Iwakoshi et al.
members of the TLR family: the TLR4 ligand LPS, derived 
from the Gram-negative bacterium   Escherichia coli  , and the 
TLR9 ligand CpG DNA16 (  34, 35  ). To examine DC sur-
vival, we cultured cells in the absence and presence of TLR 
stimulation. As shown in   Fig. 4 A  , without stimulation 
(nCPG)     45% of WT DCs underwent apoptosis at 24 h, as 
indicated by staining for annexin V and 7-amino- actinomycin 
D (7-AAD) staining.   This was in marked contrast to XBP       /       
DCs, which exhibited increased apoptosis with     65% cells 
staining positive for annexin V and 7-AAD at 24 h. In addition, 
viable cells were counted at 24 h to assess cell survival. Consis-
tent with the increased apoptosis, 46% of WT DCs were still 
viable at 24 h, whereas only 24% of XBP       /       DCs were still 
viable at that time. As reported earlier in this paper, treatment 
XBP-1s  –    GFP    –  transduced Flt3      XBP-1       /       progenitors pro-
duced signifi  cantly higher total numbers of both pDCs and 
DCs compared with   GFP  -transduced Flt3      progenitors from 
WT and XBP-1       /       BM. Collectively, these results indicate 
that ectopic expression of XBP-1s into WT and XBP-1       /       
Flt3      hematopoietic progenitors can enhance and rescue the 
development of pDCs and DCs. 
  Our results showed that there was an especially marked 
impairment in the production of the pDC subset. We won-
dered if XBP-1 might regulate both the development and 
lifespan of DCs. Therefore, we next examined whether XBP-1 
controlled DC survival. Because it has been reported that 
TLR components of the innate immune system promote DC 
survival, we examined ligands for two of the best characterized 
  Figure 2.     Constitutive expression and splicing of XBP-1 in DCs. (A) Enriched low density spleens cell were sorted for CD3    ,  CD19   ,  CD11c   ,  and 
CD11c    B220     (DX5       ) cell subsets. Purifi  ed subsets and the transformed DC line CY15 were analyzed by RT-PCR using XBP-1 and     -actin – specifi  c probes. 
*, P       0.05 when comparing with all other groups. The data represent mean values       SD from three independent experiments. (B) Total RNA from puri-
fi  ed subsets (shown in A) and CY15 cells was isolated for RT-PCR analysis. Primers spanning the splice junction in mice   Xbp-1   were used to amplify prod-
ucts of unspliced and spliced mRNA. PCR products were separated by electrophoresis on a 3% agarose gel and visualized by ethidium bromide staining. 
(C) Immunoblot analysis of XBP-1s protein in CD11c      and CY15 cells and splenic B cells stimulated with LPS. Results are representative of three separate 
experiments. (D) Electron micrographs of FACS-sorted WT and XBP-1      /      CD11c   B220     pDCs (arrows indicate ER cisternae). (E) IFN-      production  of 
FACS-sorted WT and XBP-1      /      CD11c   B220     pDCs in response to 1      M CpG for 24 h. The data represent the mean   SEM (  n     3). *, P       0.002  when 
comparing WT with XBP-1      /      samples. Bars, 50 nm.     JEM VOL. 204, October 1, 2007  2271
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  To further test the function of the XBP-1 arm of the 
UPR in DCs, we generated transformed DC lines function-
ally defi  cient in XBP-1 by transducing Cy15 cells with a 
potent dominant-negative XBP-1 (dnXBP-1) retrovirus or 
with TLR4 and TLR9 ligands increased WT DC survival 
at 24 h with     60  –  70% survival rate (  34, 35  ). However, 
XBP       /       DCs were resistant to survival signals given by TLR 
engagement (  Fig. 4 B  ). 
  Figure 3.     Decreased development and survival of XBP-1      /      DCs. (A) c-Kit    lin         –  enriched BM cells were sorted and cultured for 6 d in msFlt3L- and 
SCF-supplemented media. Flow cytometric analysis of WT and XBP-1      /      BM cells stained for CD11c and B220. Numbers in gates represent percentages of 
gated cells. (B) Graph depicts numbers of WT and XBP-1      /      DCs derived from 10  5   BM cells cultured with msFlt3L and SCF at day 6. The data represent 
mean values       SD from three independent experiments. * and **, P       0.01 when comparing CD11c and CD11c/B220 WT with XBP-1      /      samples. (C) Flow 
cytometric analysis of   GFP       cells derived from control-  GFP  –   and  XBP-1s –  GFP  – transduced  Flt3     progenitors cultured for 6 d in Flt3L- and SCF-supple-
mented media. Values represent percentages of total plotted cells. Results are representative of three independent experiments. (D) Graph depicts num-
bers of pDCs (shaded bars) and DCs (open bars) derived from 0.75       10 5    GFP -transduced  Flt3     progenitors  and  XBP-1s –  GFP  – transduced  Flt3     progenitors 
cultured with Flt3L and SCF for 6 d. Bars represent mean values       SD from three independent experiments. *, P       0.04 when comparing WT gfp with 
XBP-1      /      gfp samples; **, P       0.04 when comparing WT gfp with WT XBP-1s  –  gfp samples; ***, P       0.02 when comparing XBP-1      /      XBP-1s – gfp  with  WT 
gfp and XBP-1      /      gfp  samples.   2272 A REQUIREMENT FOR XBP-1 IN NORMAL AND MALIGNANT DENDRITIC CELLS | Iwakoshi et al.
gfp-control retrovirus. Because dnXBP-1 does not possess 
the C-terminal destabilization motif present in XBP-1u, it 
is stably expressed and effi   ciently inhibits XBP-1s  –  induced 
transactivation. Suppression of XBP-1 activity by dnXBP-1 
markedly inhibits the expression of known XBP-1  –  depen-
dent UPR target genes such as   ERdj4   and   p58  IPK     (  36, 37  ). 
No eff  ect on cell proliferation was observed at baseline. How-
ever, upon treatment with the ER stressor tunicamycin, 
dnXBP-1 Cy15 cells displayed considerably increased apop-
tosis when compared with control   GFP  -transduced Cy15 
cells, demonstrating that the IRE1  –  XBP-1 pathway contrib-
utes to the survival of transformed DCs under ER stress con-
ditions (  Fig. 4 C  ). We should note that Cy15 cells transduced 
with a potent XBP-1 siRNA were diffi   cult to stably maintain 
in culture, consistent with an essential function for XBP-1 in 
DC survival. 
  To test whether blockade of the XBP-1 signaling path-
way might alter tumor growth in vivo, CY15-gfp and 
CY15  –  dnXBP-1 cells were injected into BALB/c-RAG2       /       
mice. By 4 wk, all animals injected with 10  6   CY15-gfp cells 
had developed large numbers of macroscopically visible me-
tastases in the spleen, liver, lung, and kidney. In contrast, the 
growth and metastasis of CY15 cells expressing the dnXBP-1 
protein were greatly decreased. Although macroscopically 
visible metastases were present, the number of nodules was 
markedly reduced, and by fl  ow cytometry, the number of 
malignant CY15  –  dnXBP-1 cells was     10  –  20-fold less than 
the control CY15-gfp  –  transduced cells in the various tissues 
examined (  Fig. 4 D  ). Consistent with the in vitro studies in 
Fig. 4 C, injection of XBP-1 siRNA knockdown Cy15 cells 
led to the outgrowth of metastases containing XBP-1 siRNA  –
  nonexpressing Cy15 cells. 
  In the present study, we provide the fi  rst evidence for 
a critical function of the ER stress response in the survival 
of DCs. Chimeric mice lacking the UPR transcription fac-
tor XBP-1 had markedly reduced numbers of the four DC 
subsets, with the most severe reduction seen in the pDC 
compartment. Our data suggested that the disappearance of 
XBP-1  –  defi  cient DCs refl  ected an increased sensitivity to 
apoptotic cell death during diff  erentiation, two processes that 
are intimately linked to the lifespan of the DC and play a key 
role in controlling immune responses (  25  ). In addition, ret-
roviral transduction of the spliced form of mouse XBP-1 into 
progenitor cells into WT and XBP-1       /       Flt3      hematopoietic 
progenitors not only enhanced pDC and DC development in 
WT progenitors but also rescued the development of pDCs 
and DCs in XBP-1       /       progenitors. These results provide 
strong evidence for a key function of XBP-1 in pDC and 
DC diff  erentiation. The unexpected fi  nding that IRE1 was 
  Figure 4.     DC lines with reduced XBP-1 activity are more sensi-
tive to ER stress-induced apoptosis and exhibit decreased survival 
in vivo. (A) Increased apoptosis of XBP-1      /      DCs. WT and XBP-1      /     
DCs. Apoptotic cell death was analyzed by fl  ow cytometric staining with 
annexin V and 7-AAD. Numbers in gates represent percentages of gated 
cells. Data are representative of three to four independent experiments. 
(B) Failure to rescue apoptosis of XBP-1      /      DCs in response to TLR sig-
naling. 3       10  5   WT and XBP-1      /      pDCs were incubated with 1     M  CpG 
DNA or nCpG DNA, or 1      g/ml LPS, for 24 h. Viable WT and XBP-1      /     
cells were counted after Trypan blue dye exclusion at 24 h. Data are 
representative of three to four independent experiments. * and **, P      
0.01; and ***, P       0.025 when comparing WT with XBP-1      /      samples. 
*, P       0.01 when comparing WT versus ** and ***; *, NS when comparing 
XBP-1 versus ** and ***. (C) CY15 cells that express control   GFP  or 
dnXBP-1 –  GFP  were treated with the indicated amount of tunicamycin 
for 24 h. Apoptotic cell death was analyzed by fl  ow cytometric staining 
with annexin V and 7-AAD. (D) 10  6   control   GFP  or dnXBP-1  –    GFP  CY15 
cells were injected s.c. into RAG1      /      BALB/c mice. Mice were killed 30 d 
later, and the percentage of CY15-  GFP  cells in the respective organs was 
determined by fl  ow cytometry. The data represent mean values       SD 
from three independent experiments. *, P       0.01; and **, P       0.05  when 
comparing with XBP-1      /      samples.   JEM VOL. 204, October 1, 2007  2273
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extend or shorten the lifespan of a DC to achieve tolerance 
or immunity and that may be therapeutic in the setting of 
malignant histiocytosis. 
  MATERIAL AND METHODS 
  Mice.     129SV6, C57BL/6, and BALB/c RAG1       /       mice were purchased 
from Taconic and used at 6  –  8 wks of age. The generation and screening of 
XBP-1/RAG-2       /       chimeric mice were done as previously described (  1  ). 
All mice were housed in a pathogen-free facility at the Harvard School of 
Public Health, and all animal studies were performed according to institu-
tional and National Institutes of Health guidelines for animal use and care. 
  Reagents and cell lines.     The sequences of phosphorothioate ODNs 
(QIAGEN) are as follows: TCCATGACGTTCCTGATGCT for stimula-
tory CpG ODN and TTCATGAGCTTCCTGATGCT for control (nCpG) 
ODN. Endotoxin-free LPS (InvivoGen). The CY15 DC line was provided 
by T. Blankenstein (Institute of Immunology, Berlin, Germany). 
  Purifi  cation and isolation of DCs.     DCs were isolated as previously de-
scribed (  38  ). In brief, CD11c      DCs were isolated from collagenase-treated 
spleen preparations and enriched by centrifugation in a cell separation medium 
(Accudenz; Accurate Chemicals). B lymphocytes and NK cells were depleted 
by using coated magnetic beads (anti-CD19 and anti-DX5, respectively) before 
FACS sorting (Miltenyi Biotec). DC subsets were sorted and analyzed using a 
FACSAria (Becton Dickinson) and DIVA software (Becton Dickinson). 
  Flow cytometry.     Cells were stained with the following mouse reactive anti-
bodies: anti-CD16/32 (2.4G2); anti  –  MHC class II (IA/IE; 2G9); anti-CD8      
(53-6.7); anti-CD11c (HL3); anti-CD4 (GK1.5); anti-B220 (RA3-6B2); 
anti-CD11b (M1/70); anti-CD86 (GL1); and pan-NK (DX5). To distin-
guish host from donor DCs in chimaeras, we used the surface marker LY9.1 
(30C7), carried by the 129 but not the B6 strain (  39  ). For apoptosis assays, 
cells were stained with PE-conjugated annexin V and 7-AAD (BD Biosciences) 
according to the manufacturer  ’  s instructions. Analyses of stained cells were 
performed on a FACSCalibur (BD Bioscience) with CellQuest software (BD 
Bioscience). All antibodies were purchased from BD Bioscience. 
  In vitro DC diff  erentiation and survival assay.     Hematopoietic progen-
itors were isolated as previously described (  33  ), with minor changes. BM 
cells were isolated and enriched for c-Kit      cells by using APC-conjugated 
c-Kit antibodies (BD Biosciences) and APC microbeads (Miltenyi Biotec). 
Cells were then stained with mAbs for lineage markers (CD3     , 145-2C11; 
CD4, GK1.5; CD8, 53-6.7; B220, RA3-6B2; CD19, MB19-1; CD11b, 
M1/70; Gr-1, RB6-8C5; and TER119, TER119), IL-7R              (A7R34), and 
Thy1.1         (19XE5; BD Biosciences). LY9     c-Kit     Lin         BM progenitors were 
sorted and analyzed using a FACSAria with DIVA software. For XBP-1/
RAG-2       /       chimeric mice, the embryonic stem cells were derived from the 
129 strain. Therefore, we used the surface marker Ly9.1, which is an allele 
that is carried by the 129 but not the B6 strain (Rag2       /       background) to 
  purify donor from host progenitors. Progenitors were cultured in RPMI 1640 
supplemented with 10% FCS, 10       4   M 2-     ME, sodium pyruvate, and anti-
biotics (100 ng/ml msFlt3L and 10 ng/ml msSCF; R  &  D Systems). Media 
was replaced every 3 d with new media and cytokines. For survival assays, 
3       10  5   FACS-sorted CD11c      cells per well were plated at 1      M CpG DNA 
or nCpG DNA, or 1      g/ml LPS, for 24 h. Apoptosis assays using annexin V 
and 7-AAD were performed as described in Flow cytometry and expressed 
as the percentage of apoptotic cells. DC survival was quantifi  ed by using 
Trypan blue dye exclusion at 24 h. Statistical signifi  cance was evaluated by 
using the Student  ’  s   t   test. 
  Retroviral transduction of hematopoietic progenitors.     Hematopoi-
etic progenitors were transduced as previously described (  33  ), with minor 
changes. The full-length mouse   XBP-1s   RV-gfp was used to make retro-
virus supernatants, as previously described (  11  ). Supernatants were used to 
transduce GP+E-86 cells. After 48 h, the   GFP  -expressing GP+E-86 cells 
constitutively active in freshly isolated DCs led to the pre-
diction that its inhibition might result in increased apoptosis 
of transformed DCs. Indeed, the growth and metastasis of a 
malignant DC line was greatly compromised when XBP-1 
activity was reduced. This is consistent with previous results 
from our laboratory that have shown the proapoptotic proteins 
BAX and BAK as essential components of the UPR that in-
teract with the IRE1 cytosolic domain under stress conditions 
to modulate IRE1 signaling. However, levels of transcripts 
encoding BCL-2 family members and BH3-only proteins 
were normal in XBP-1       /       splenic DCs (unpublished data). 
  The extraordinarily high levels of XBP-1 transcripts in 
pDCs and, more importantly, the constitutive UPR activa-
tion, as indicated by the presence of abundant XBP-1s pro-
tein in DCs, is without precedent in other tissues. This was 
particularly noticeable in the pDC subset and manifested by 
the more profound reduction of pDCs compared with con-
ventional DCs. pDCs are a distinct DC population with 
spherical plasmacytoid morphology that, interestingly, re-
sembles plasma cells, the only known lymphoid cells that re-
quire XBP-1. During B cell diff  erentiation to the plasma cell, 
a remodeling process occurs in which the ER undergoes 
massive expansion to accommodate the large quantities of 
newly synthesized Ig for secretion. Similarly, after activation 
by bacterial DNA or by viral infection, pDCs develop multiple 
cytoplasmic extensions and an expanded ER, and produce 
large amounts of IFN-     . Therefore, it makes sense that a 
vigorous UPR is required in this cell; however, it functions 
at an earlier stage, as indicated by constitutive UPR activa-
tion, suggesting that the pDC is being readied for prompt 
IFN-      secretion in the setting of viral infection. Indeed, 
ER expansion and IFN-      levels are diminished in XBP-1  –
  defi  cient pDCs (  Fig. 2, D and E  ). Although conventional 
DCs are not known to possess plasmacytoid morphology or 
secrete excessive cytokines, basal level XBP-1 splicing dem-
onstrates considerable activation of this vital arm of the UPR. 
Our data suggest that a basal XBP-1 activation state allows for 
optimal DC function. In the absence of XBP-1, DC homeo-
stasis is thus dysregulated, resulting in impaired survival dur-
ing unstimulated and stimulated conditions. As mentioned 
earlier, at this point in our studies we have no evidence to 
support cross talk between the ER stress and TLR signaling 
pathways in DCs via protein load, as TLR stimulation of 
pDCs and DCs fails to either increase XBP-1 mRNA or 
splicing. Hence, we suggest that the XBP-1 survival pathway 
acts at an earlier stage and is distinct from the TLR-induced 
NF-     B  –  dependent pathway. Consistent with this function at 
an earlier stage is the inability of TLR engagement to rescue 
the impaired survival of XBP-1  –  defi  cient DCs. In these stud-
ies, we only provide evidence for the eff  ect of XBP-1 defi  -
ciency on cell death induced by the ER stress response; future 
studies will aim to examine other forms of DC survival/death. 
Identifying the factors that evoke constitutive UPR activa-
tion before DC maturation, excessive protein secretion, and 
ER expansion will be of great interest. This pathway off  ers a 
novel target for the development of small molecules that can 2274 A REQUIREMENT FOR XBP-1 IN NORMAL AND MALIGNANT DENDRITIC CELLS | Iwakoshi et al.
       2  .   Lipson  ,   K.L.  ,   S.G.     Fonseca  ,   S.     Ishigaki  ,   L.X.     Nguyen  ,   E.     Foss  ,   R.   
  Bortell  ,   A.A.     Rossini  , and   F.     Urano  .   2006  .   Regulation of insulin bio-
synthesis in pancreatic beta cells by an endoplasmic reticulum-resident 
protein kinase IRE1.       Cell Metab.       4  :  245    –    254  .   
       3  .   Koumenis  ,   C.     2006  .   ER stress, hypoxia tolerance and tumor progression.   
    Curr. Mol. Med.       6  :  55    –    69  .   
       4  .   Paschen  ,   W.  , and   T.     Mengesdorf  .   2005  .   Endoplasmic reticulum stress 
response and neurodegeneration.       Cell Calcium    .   38  :  409    –    415  .   
       5  .   Liou  ,   H.C.  ,   M.R.     Boothby  ,   P.W.     Finn  ,   R.     Davidon  ,   N.     Nabavi  ,   N.J.   
  Zeleznik-Le  ,   J.P.     Ting  , and   L.H.     Glimcher  .   1990  .   A new member of the 
leucine zipper class of proteins that binds to the HLA DR alpha promoter.   
    Science    .   247  :  1581    –    1584  .   
       6  .   Shen  ,   X.  ,   R.E.     Ellis  ,   K.     Lee  ,   C.Y.     Liu  ,   K.     Yang  ,   A.     Solomon  ,   H.   
  Yoshida  ,  R.    Morimoto  ,  D.M.    Kurnit  ,  K.    Mori  , and  R.J.    Kaufman  .  2001  . 
  Complementary signaling pathways regulate the unfolded protein re-
sponse and are required for   C. elegans   development.       Cell    .   107  :  893    –    903  .   
       7  .   Yoshida  ,   H.  ,   T.     Matsui  ,   A.     Yamamoto  ,   T.     Okada  , and   K.     Mori  .   2001  . 
  XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response 
to ER stress to produce a highly active transcription factor.       Cell    .   107  : 
881    –    891  .   
       8  .   Calfon  ,   M.  ,   H.     Zeng  ,   F.     Urano  ,   J.H.     Till  ,   S.R.     Hubbard  ,   H.P.     Harding  , 
  S.G.     Clark  , and   D.     Ron  .   2002  .   IRE1 couples endoplasmic reticulum 
load to secretory capacity by processing the XBP-1 mRNA.       Nature    . 
  415  :  92    –    96  .   
       9  .   Reimold  ,   A.M.  ,   A.     Etkin  ,   I.     Clauss  ,   A.     Perkins  ,   D.S.     Friend  ,   J.     Zhang  , 
  H.F.     Horton  ,   A.     Scott  ,   S.H.     Orkin  ,   M.C.     Byrne  ,   et al  .   2000  .   An essen-
tial role in liver development for transcription factor XBP-1.       Genes Dev.     
  14  :  152    –    157  .   
      10  .   Lee  ,   A.H.  ,   G.C.     Chu  ,   N.N.     Iwakoshi  , and   L.H.     Glimcher  .   2005  .   XBP-1 is 
required for biogenesis of cellular secretory machinery of exocrine glands.   
    EMBO J.       24  :  4368    –    4380  .   
        11  .   Iwakoshi  ,   N.N.  ,   A.H.     Lee  ,   P.     Vallabhajosyula  ,   K.L.     Otipoby  ,   K.   
  Rajewsky  , and   L.H.     Glimcher  .   2003  .   Plasma cell diff  erentiation and the 
unfolded protein response intersect at the transcription factor XBP-1.   
    Nat. Immunol.       4  :  321    –    329  .   
        12  .   McKenna  ,   H.J.  ,   K.L.     Stocking  ,   R.E.     Miller  ,   K.     Brasel  ,   T.     De Smedt  ,   E.   
  Maraskovsky  ,   C.R.     Maliszewski  ,   D.H.     Lynch  ,   J.     Smith  ,   B.     Pulendran  , 
  et al  .   2000  .   Mice lacking fl  t3 ligand have defi  cient hematopoiesis aff  ecting 
hematopoietic progenitor cells, dendritic cells, and natural killer cells.   
    Blood    .   95  :  3489    –    3497  .   
        13  .   Maraskovsky  ,   E.  ,   K.     Brasel  ,   M.     Teepe  ,   E.R.     Roux  ,   S.D.     Lyman  ,   K.   
  Shortman  , and   H.J.     McKenna  .   1996  .   Dramatic increase in the numbers 
of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple 
dendritic cell subpopulations identifi  ed.       J. Exp. Med.       184  :  1953    –    1962  .   
        14  .   Caux  ,   C.  ,   B.     Vanbervliet  ,   C.     Massacrier  ,   C.     Dezutter-Dambuyant  ,   B.   
  de Saint-Vis  ,   C.     Jacquet  ,   K.     Yoneda  ,   S.     Imamura  ,   D.     Schmitt  , and   J.   
  Banchereau  .   1996  .   CD34  +   hematopoietic progenitors from human cord 
blood diff  erentiate along two independent dendritic cell pathways in 
response to GM-CSF + TNF-     .       J. Exp. Med.       184  :  695    –    706  .   
        15  .   Sallusto  ,   F.  , and   A.     Lanzavecchia  .   1994  .   Effi   cient presentation of soluble 
antigen by cultured human dendritic cells is maintained by granulocyte/
macrophage colony-stimulating factor plus interleukin 4 and downreg-
ulated by tumor necrosis factor      .       J. Exp. Med.       179  :  1109    –    1118  .   
        16  .   Nagai  ,   Y.  ,   K.P.     Garrett  ,   S.     Ohta  ,   U.     Bahrun  ,   T.     Kouro  ,   S.     Akira  ,   K.   
  Takatsu  , and   P.W.     Kincade  .   2006  .   Toll-like receptors on hematopoietic 
progenitor cells stimulate innate immune system replenishment.       Immunity    . 
  24  :  801    –    812  .   
        17  .   Wu  ,   L.  ,   A.     D  ’  Amico  ,   K.D.     Winkel  ,   M.     Suter  ,   D.     Lo  , and   K.     Shortman  . 
  1998  .  RelB is essential for the development of myeloid-related CD8alpha −   
dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells.   
    Immunity    .   9  :  839    –    847  .   
        18  .   Rathinam  ,   C.  ,   R.     Geff  ers  ,   R.     Yucel  ,   J.     Buer  ,   K.     Welte  ,   T.     Moroy  , and 
  C.     Klein  .   2005  .   The transcriptional repressor Gfi  1 controls STAT3-
dependent dendritic cell development and function.       Immunity    .   22  : 
717    –    728  .   
        19  .   Hacker  ,   C.  ,   R.D.     Kirsch  ,   X.S.     Ju  ,   T.     Hieronymus  ,   T.C.     Gust  ,   C.   
  Kuhl  ,   T.     Jorgas  ,   S.M.     Kurz  ,   S.     Rose-John  ,   Y.     Yokota  , and   M.     Zenke  . 
  2003  .   Transcriptional profi  ling identifi  es Id2 function in dendritic cell 
development.       Nat. Immunol.       4  :  380    –    386  .   
were FACS sorted and expanded. For transduction of FLT3R     c-Kit     Lin         
BM progenitor cells, GP+E-86 cells were irradiated (20 Gy) and plated in 
24-well plates at 0.75       10  5   cells per well for 24 h. Sorted progenitor cells 
were transduced by co-culture with GP+E-86 for 18 h in IMDM (Invitro-
gen) containing 2% FCS, 4      g/ml polybrene (Sigma-Aldrich), 100 ng/ml 
mouse Flt3L         protein (R  &  D Systems), 10 ng/ml mSCF (R  &  D Systems), 
and 10 ng/ml mIL-11 (R  &  D Systems). Transduced cells were removed by 
gently dispersing and placed in Flt3L diff  erentiation cultures. 
  RNA, ELISA, and protein analysis.     Total RNA was isolated from tissues 
using TRI  zol   reagent (Invitrogen). cDNA was synthesized from RNA sam-
ples using the iScript cDNA synthesis kit containing oligo (dT) and random 
hexamer primers (Bio-Rad Laboratories). Quantitative real-time PCR reac-
tions using SYBR green fl  uorescent reagent were run in an ABI PRISM 7700 
system (Applied Biosystems). The relative amounts of mRNAs were calculated 
from the comparative threshold cycle (C     ) values by using      -actin as control. 
Primer sequences designed by Primer Express software (Applied Biosystems) 
have been previously described (  10  ). Whole-cell lysates of DCs were prepared 
in RIPA buff  er (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% 
Triton X-100, 1% sodium deoxycholate, 0.1% SDS). Western blot analysis 
was performed as previously described (  11  ), with anti  –  XBP-1 pAb. ELISA for 
IFN-      was done by using 5      g/ml of capture mAb, 200 U/ml of secondary 
pAb (PBL Biomedical Laboratories), and a 1:1,000 dilution of alkaline phos-
phatase  –  conjugated anti  –  rabbit IgG (Jackson ImmunoResearch Laboratories). 
Statistical signifi  cance was evaluated using the Student  ’  s   t   test. 
  Electron microscopy.     Cells were fi  xed in 2.5% glutaraldehyde in 0.1 M 
cacodylate, pH 7.4, for 1 h at room temperature. After washing in cacodylate 
buff  er, cells were postfi  xed for 1 h in 1% osmium tetroxide in the same buf-
fer at room temperature, washed again, and stained   “  en bloc  ”   in 2% uranyl 
acetate in 0.05 M sodium maleate, pH 5.2, for 1 h at room temperature. 
  After dehydration in a graded series of ethanol, cells were embedded in 
  epoxy resin (Embed 812; Electron Microscopy Sciences). Ultrathin sections 
were cut on a ultramicrotome (Reichert), collected on formvar- and carbon-
coated grids, stained with 2% uranyl acetate and lead citrate, and viewed on 
an electron microscope (Tecnai 12 BioTWIN; FEI Company). 
  In vitro and in vivo growth of CY15 cells.     Retroviral transduction to 
produce   GFP   and dnXBP-1  –    GFP   CY15 cells was performed as previously 
described (  36  ). Assessment of metastasis of CY15-  GFP   and dnXBP-1 cells 
was performed as previously described (  31  ), with minor modifi  cations. In 
brief, 10  6   CY15 cells were injected s.c. into RAG1       /       BALB/c mice, and 
mice were killed 30 d later. The liver, lung and kidney, and spleen were har-
vested and digested with collagenase treatment (as described for DCs) for 4 h 
at 37  °  C with occasional shaking. The percentage of CY15-  GFP   cells in each 
organ was determined by fl  ow cytometry on a FACSCalibur with CellQuest 
software. Statistical signifi  cance was evaluated using the Student  ’  s   t   test. 
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